Home » Stocks » ARCA biopharma

ARCA biopharma, Inc. (ABIO)

Stock Price: $4.08 USD -0.08 (-1.92%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $4.05 -0.03 (-0.74%) Oct 21, 7:48 PM

Stock Price Chart

Key Info

Market Cap 24.09M
Revenue (ttm) n/a
Net Income (ttm) -5.00M
Shares Out 5.91M
EPS (ttm) -3.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $4.08
Previous Close $4.16
Change ($) -0.08
Change (%) -1.92%
Day's Open 4.17
Day's Range 4.05 - 4.24
Day's Volume 182,752
52-Week Range 2.21 - 22.00

More Stats

Market Cap 24.09M
Enterprise Value 13.05M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 5.91M
Float 5.88M
EPS (basic) -3.01
EPS (diluted) -3.07
FCF / Share -2.67
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 145,800
Short Ratio 0.16
Short % of Float 2.48%
Beta 2.88
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 3.76
Revenue n/a
Operating Income -5.18M
Net Income -5.00M
Free Cash Flow -4.78M
Net Cash 11.04M
Net Cash / Share 1.87
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -29.38%
ROE -51.34%
ROIC 749.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $4.08
Target: 7.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-5.81-8.12-18.71-16.61-11.46-9.69-6.94-4.32-7.36-9.18
Net Income-5.48-7.93-18.49-16.44-11.45-9.69-6.94-4.32-5.36-8.42
Shares Outstanding1.320.770.580.500.350.
Earnings Per Share-4.15-10.31-31.86-32.58-32.76-59.58-131.03-244.42-404.42-748.35
Operating Cash Flow-4.80-8.24-17.47-14.99-10.53-9.41-5.29-4.08-6.96-8.32
Capital Expenditures----0.01-0.01-0.02-0.03-0.01-
Free Cash Flow-4.81-8.25-17.48-15.00-10.55-9.43-5.32-4.08-6.95-8.32
Cash & Equivalents8.366.6111.7521.1638.8015.3516.762.925.947.03
Net Cash / Debt8.366.6111.7521.1638.8015.3516.762.925.947.03
Book Value7.616.0310.2822.1938.0714.7415.582.915.736.77
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ARCA biopharma, Inc.
Country United States
Employees 13
CEO Michael R. Bristow

Stock Information

Ticker Symbol ABIO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ABIO


ARCA biopharma operates as a biopharmaceutical company applying a precision medicine approach to developing and commercializing genetically targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride) is pharmacogenetically-targeted beta-adrenergic receptor antagonist, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of AB171, a thiol-substituted isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.